Trial
NCT00212407
New York Blood Center National Cord Blood Program
Early Phase ITERMINATEDREGULATORYConfidence: MEDIUM
Sponsor
New York Blood Center
Collaborators
—
Condition
Leukemia
Intervention
Umbilical Cord Blood Transplantation
Why stopped
Study NCT01656603 supersedes this study; FDA IND 6637
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-11-02